CORTEVA INC (CTVA) Stock Fundamental Analysis

NYSE:CTVA • US22052L1044

75.03 USD
+0.92 (+1.24%)
At close: Feb 13, 2026
75.03 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CTVA. CTVA was compared to 83 industry peers in the Chemicals industry. CTVA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CTVA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • CTVA had positive earnings in the past year.
  • In the past year CTVA had a positive cash flow from operations.
  • Each year in the past 5 years CTVA has been profitable.
  • In the past 5 years CTVA always reported a positive cash flow from operatings.
CTVA Yearly Net Income VS EBIT VS OCF VS FCFCTVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B

1.2 Ratios

  • CTVA has a better Return On Assets (2.55%) than 63.86% of its industry peers.
  • With a decent Return On Equity value of 4.53%, CTVA is doing good in the industry, outperforming 63.86% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 5.93%, CTVA is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CTVA is in line with the industry average of 6.13%.
  • The 3 year average ROIC (5.07%) for CTVA is below the current ROIC(5.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.55%
ROE 4.53%
ROIC 5.93%
ROA(3y)2.16%
ROA(5y)2.67%
ROE(3y)3.76%
ROE(5y)4.55%
ROIC(3y)5.07%
ROIC(5y)4.44%
CTVA Yearly ROA, ROE, ROICCTVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 -4 6 -6

1.3 Margins

  • CTVA has a Profit Margin of 6.29%. This is in the better half of the industry: CTVA outperforms 72.29% of its industry peers.
  • In the last couple of years the Profit Margin of CTVA has grown nicely.
  • CTVA's Operating Margin of 15.05% is fine compared to the rest of the industry. CTVA outperforms 78.31% of its industry peers.
  • In the last couple of years the Operating Margin of CTVA has grown nicely.
  • With an excellent Gross Margin value of 47.29%, CTVA belongs to the best of the industry, outperforming 90.36% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CTVA has grown nicely.
Industry RankSector Rank
OM 15.05%
PM (TTM) 6.29%
GM 47.29%
OM growth 3Y10.86%
OM growth 5Y20.48%
PM growth 3Y-1.46%
PM growth 5Y5.59%
GM growth 3Y5.55%
GM growth 5Y3.32%
CTVA Yearly Profit, Operating, Gross MarginsCTVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • CTVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CTVA has less shares outstanding than it did 1 year ago.
  • CTVA has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CTVA has an improved debt to assets ratio.
CTVA Yearly Shares OutstandingCTVA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
CTVA Yearly Total Debt VS Total AssetsCTVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 2.37 indicates that CTVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CTVA has a better Altman-Z score (2.37) than 62.65% of its industry peers.
  • The Debt to FCF ratio of CTVA is 0.92, which is an excellent value as it means it would take CTVA, only 0.92 years of fcf income to pay off all of its debts.
  • CTVA has a better Debt to FCF ratio (0.92) than 96.39% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that CTVA is not too dependend on debt financing.
  • CTVA's Debt to Equity ratio of 0.07 is amongst the best of the industry. CTVA outperforms 89.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.92
Altman-Z 2.37
ROIC/WACC0.39
WACC15.03%
CTVA Yearly LT Debt VS Equity VS FCFCTVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • CTVA has a Current Ratio of 1.43. This is a normal value and indicates that CTVA is financially healthy and should not expect problems in meeting its short term obligations.
  • CTVA has a worse Current ratio (1.43) than 74.70% of its industry peers.
  • CTVA has a Quick Ratio of 1.43. This is a bad value and indicates that CTVA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.96, CTVA is doing worse than 63.86% of the companies in the same industry.
  • CTVA does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.96
CTVA Yearly Current Assets VS Current LiabilitesCTVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CTVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.20%, which is quite impressive.
  • Measured over the past years, CTVA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.22% on average per year.
  • Looking at the last year, CTVA shows a small growth in Revenue. The Revenue has grown by 2.92% in the last year.
  • The Revenue has been growing slightly by 4.12% on average over the past years.
EPS 1Y (TTM)30.2%
EPS 3Y7.8%
EPS 5Y17.22%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)2.92%
Revenue growth 3Y-0.1%
Revenue growth 5Y4.12%
Sales Q2Q%-1.71%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.96% on average over the next years.
  • The Revenue is expected to grow by 2.35% on average over the next years.
EPS Next Y12.4%
EPS Next 2Y12.45%
EPS Next 3Y11.44%
EPS Next 5Y6.96%
Revenue Next Year3.57%
Revenue Next 2Y3.34%
Revenue Next 3Y2.63%
Revenue Next 5Y2.35%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTVA Yearly Revenue VS EstimatesCTVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B 20B
CTVA Yearly EPS VS EstimatesCTVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 22.60, the valuation of CTVA can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as CTVA.
  • When comparing the Price/Earnings ratio of CTVA to the average of the S&P500 Index (26.68), we can say CTVA is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 20.11, the valuation of CTVA can be described as rather expensive.
  • CTVA's Price/Forward Earnings is on the same level as the industry average.
  • CTVA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.6
Fwd PE 20.11
CTVA Price Earnings VS Forward Price EarningsCTVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTVA is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, CTVA is valued a bit cheaper than the industry average as 74.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.92
EV/EBITDA 12.68
CTVA Per share dataCTVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CTVA does not grow enough to justify the current Price/Earnings ratio.
  • CTVA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.82
PEG (5Y)1.31
EPS Next 2Y12.45%
EPS Next 3Y11.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.97%, CTVA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.15, CTVA has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.84, CTVA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

  • On average, the dividend of CTVA grows each year by 30.66%, which is quite nice.
  • CTVA has been paying a dividend for over 5 years, so it has already some track record.
  • As CTVA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)30.66%
Div Incr Years5
Div Non Decr Years5
CTVA Yearly Dividends per shareCTVA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 43.42% of the earnings are spent on dividend by CTVA. This is a bit on the high side, but may be sustainable.
  • The dividend of CTVA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP43.42%
EPS Next 2Y12.45%
EPS Next 3Y11.44%
CTVA Yearly Income VS Free CF VS DividendCTVA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B
CTVA Dividend Payout.CTVA Dividend Payout, showing the Payout Ratio.CTVA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CORTEVA INC

NYSE:CTVA (2/13/2026, 8:04:00 PM)

After market: 75.03 0 (0%)

75.03

+0.92 (+1.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-03
Earnings (Next)05-05
Inst Owners87.17%
Inst Owner Change-4.74%
Ins Owners0.07%
Ins Owner Change1.81%
Market Cap50.43B
Revenue(TTM)17.40B
Net Income(TTM)1.09B
Analysts80
Price Target80.02 (6.65%)
Short Float %1.86%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.7
Dividend Growth(5Y)30.66%
DP43.42%
Div Incr Years5
Div Non Decr Years5
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.75%
Min EPS beat(2)-2.11%
Max EPS beat(2)57.61%
EPS beat(4)3
Avg EPS beat(4)23.93%
Min EPS beat(4)-2.11%
Max EPS beat(4)57.61%
EPS beat(8)6
Avg EPS beat(8)5.31%
EPS beat(12)9
Avg EPS beat(12)18.24%
EPS beat(16)13
Avg EPS beat(16)31.25%
Revenue beat(2)1
Avg Revenue beat(2)-2.87%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)3.77%
Revenue beat(4)2
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)3.77%
Revenue beat(8)2
Avg Revenue beat(8)-4.44%
Revenue beat(12)4
Avg Revenue beat(12)-3.86%
Revenue beat(16)7
Avg Revenue beat(16)-2.58%
PT rev (1m)1.11%
PT rev (3m)0.12%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)0.77%
EPS NY rev (1m)0.14%
EPS NY rev (3m)2.18%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)0.28%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 22.6
Fwd PE 20.11
P/S 2.9
P/FCF 17.92
P/OCF 14.81
P/B 2.09
P/tB 9.38
EV/EBITDA 12.68
EPS(TTM)3.32
EY4.42%
EPS(NY)3.73
Fwd EY4.97%
FCF(TTM)4.19
FCFY5.58%
OCF(TTM)5.07
OCFY6.75%
SpS25.89
BVpS35.92
TBVpS8
PEG (NY)1.82
PEG (5Y)1.31
Graham Number51.8
Profitability
Industry RankSector Rank
ROA 2.55%
ROE 4.53%
ROCE 8.53%
ROIC 5.93%
ROICexc 6.95%
ROICexgc 24.52%
OM 15.05%
PM (TTM) 6.29%
GM 47.29%
FCFM 16.18%
ROA(3y)2.16%
ROA(5y)2.67%
ROE(3y)3.76%
ROE(5y)4.55%
ROIC(3y)5.07%
ROIC(5y)4.44%
ROICexc(3y)5.74%
ROICexc(5y)5.03%
ROICexgc(3y)19.34%
ROICexgc(5y)16.75%
ROCE(3y)7.3%
ROCE(5y)6.39%
ROICexgc growth 3Y19.31%
ROICexgc growth 5Y31.21%
ROICexc growth 3Y14.02%
ROICexc growth 5Y29.17%
OM growth 3Y10.86%
OM growth 5Y20.48%
PM growth 3Y-1.46%
PM growth 5Y5.59%
GM growth 3Y5.55%
GM growth 5Y3.32%
F-Score7
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.92
Debt/EBITDA 0.44
Cap/Depr 49.13%
Cap/Sales 3.4%
Interest Coverage 250
Cash Conversion 89.12%
Profit Quality 257.31%
Current Ratio 1.43
Quick Ratio 0.96
Altman-Z 2.37
F-Score7
WACC15.03%
ROIC/WACC0.39
Cap/Depr(3y)48.97%
Cap/Depr(5y)48.5%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.5%
Profit Quality(3y)195.9%
Profit Quality(5y)146.69%
High Growth Momentum
Growth
EPS 1Y (TTM)30.2%
EPS 3Y7.8%
EPS 5Y17.22%
EPS Q2Q%-31.25%
EPS Next Y12.4%
EPS Next 2Y12.45%
EPS Next 3Y11.44%
EPS Next 5Y6.96%
Revenue 1Y (TTM)2.92%
Revenue growth 3Y-0.1%
Revenue growth 5Y4.12%
Sales Q2Q%-1.71%
Revenue Next Year3.57%
Revenue Next 2Y3.34%
Revenue Next 3Y2.63%
Revenue Next 5Y2.35%
EBIT growth 1Y24.95%
EBIT growth 3Y10.75%
EBIT growth 5Y25.45%
EBIT Next Year39.38%
EBIT Next 3Y15.87%
EBIT Next 5Y11.51%
FCF growth 1Y81.85%
FCF growth 3Y119.28%
FCF growth 5Y12.12%
OCF growth 1Y58.79%
OCF growth 3Y57.49%
OCF growth 5Y10.54%

CORTEVA INC / CTVA FAQ

What is the ChartMill fundamental rating of CORTEVA INC (CTVA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CTVA.


What is the valuation status for CTVA stock?

ChartMill assigns a valuation rating of 4 / 10 to CORTEVA INC (CTVA). This can be considered as Fairly Valued.


How profitable is CORTEVA INC (CTVA) stock?

CORTEVA INC (CTVA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CTVA stock?

The Price/Earnings (PE) ratio for CORTEVA INC (CTVA) is 22.6 and the Price/Book (PB) ratio is 2.09.


How financially healthy is CORTEVA INC?

The financial health rating of CORTEVA INC (CTVA) is 7 / 10.